EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 2 of 3 (Hits 21 to 40 of 44)
ID
Country
PT provider
PT scheme
Last changed
1138638 Canada CMPT - Canadian Microbiology Proficiency Testing CMPT - Canadian Microbiology Proficiency Testing COVID-19 COVID-19 2024-01-23
PT name (COVID-19)
Tested property (SARS CoV-2)

1050992 France CTCB CTCB RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] 2023-05-24
PT name (RNA SARS-CoV2 (virology))
Scheme name in national language (ARN SARS-CoV2 (virologie))
Test item (Detection of SARS-CoV2 RNA)
Tested property (ARN SARS-CoV2 - cell culture supernatant)

907768 Germany Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] 2021-11-25
PT name (Antibodies against SARS-CoV-2)
Scheme name in national language (Antikörper gegen SARS-CoV-2)
Tested property (Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG)

824901 Germany Reference Institute for Bioanalytics Reference Institute for Bioanalytics SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] 2021-02-16
PT name (SARS-CoV-2 Immunology)
Scheme name in national language (SARS-CoV-2 Immunologie)
Tested property (Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA)

1163321 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] 2024-04-16
Tested property (influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated))

1163338 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] 2024-04-16
PT name (Virus Genome Detection – SARS-CoV-2 (409))
Scheme name in national language (Virusgenom-Nachweis - SARS-CoV-2 (409))
Tested property (The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2)

1163345 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] 2024-04-16
PT name (Virus Genome Detection – SARS-CoV-2 sequence analysis (417))
Remarks (Please note: Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2)
Scheme name in national language (Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417))
Tested property (Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing)

1163304 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] 2024-04-16
Tested property (incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively)

437169 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340) [Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)] Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340) [Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)] 2024-04-16
PT name (Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340))
Scheme name in national language (Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340))
Tested property (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV) (Option for differentiaton between SARS-CoV-2, MERS-CoV and other human coronaviruses (samples which) (contain SARS-CoV-2 and MERS-CoV, repectively, are inactivated)

1160040 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] 2024-04-16
PT name (Virus Antigen Detection – SARS-CoV-2 (Ag) (410))
Remarks (samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen. The interdisciplinary, non-profit)
Scheme name in national language (Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410))
Tested property (SARS-CoV-2 antigen)

1169419 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] 2024-05-14
PT name (Virus Immunology – SARS-CoV-2 (Ab) (416))
Scheme name in national language (Virusimmunologie - SARS-CoV-2 (Ak) (416))
Tested property (Anti-SARS-CoV-2 total (without differentiation of IgG, IgA and IgM)) (Anti-SARS-CoV-2 IgG) (Anti-SARS-CoV-2 IgG avidity) (Anti-SARS-CoV-2 IgA) (Anti-SARS-CoV-2 IgM (not certified))

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
PT name (SARS-CoV-2, molecular detection)
Scheme name in national language (SARS-CoV-2, molecular detection)
Tested property (SARS-CoV-2 virus)

1129430 Spain ielab ielab SARS-CoV-2 [SARS-CoV-2] SARS-CoV-2 [SARS-CoV-2] 2023-11-29
PT name (SARS-CoV-2)
Scheme name in national language (SARS-CoV-2)
Tested property (SARS-CoV-2)

883284 Thailand Department of Medical Sciences PT provider (DMSc PT provider) Department of Medical Sciences PT provider (DMSc PT provider) SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] 2024-01-09
PT name (SARS-CoV-2 detection by Real-time RT-PCR)
Scheme name in national language (SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข))

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Tested property (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Testing method (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-09-06
Test item (Surface testing (swab rinsate) for SARS-CoV-2 molecular)
Tested property (SARS-CoV-2)

820055 United Kingdom INSPEC International Limited INSPEC International Limited Personal Protective Equipment [Personal Protective Equipment] Personal Protective Equipment [Personal Protective Equipment] 2021-01-18
Related legislation or standard (European PPE Regulation (EU 2016/425) National legislation regarding PPE for Covid-19)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

925094 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] 2022-05-13
PT name (Molecular detection of SARS-CoV-2)
Scheme name in national language (Molecular detection of SARS-CoV-2)
Test item (/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed))
Tested property (SARS-CoV-2 nucleic acid)

699949 United Kingdom UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies 2023-05-30
PT name (UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies)
Tested property (SARS-CoV-2 / COVID-19 Antibodies)

Page 2 of 3 (Hits 21 to 40 of 44)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5